White Papers
Is Pharma Ready To Embrace Virtual Trials
Using a virtual, or decentralized, approach to clinical trials has the potential to improve patient experience and data quality while also accelerating the time it takes to get new drugs on the market. Although these benefits have been apparent for years, the COVID-19 pandemic created an urgent need to implement virtual approaches.
Effect Of Excipient Choices On Topical Formulations
Our latest whitepaper shows how excipient choices can have a real impact on a product’s manufacturing economics and commercial success.
